Apoptosis in fimbriae of fallopian tubes and endometrium in pyoinflammatory adnexal diseases

Bulletin of Experimental Biology and Medicine

Volumn 135, Issue 2, 2003, Pages 150-153

  Zhdanov, A V ^a   Kurbanova, D F ^b   Davydova, M P ^c   Sosulina, L Yu ^d   Ezhova, L S ^a   Sukhikh, G T ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d M M Shemyakin/Yu A Ovchinnikov   (Russian Federation)

Author keywords

Apoptosis; Apoptosis inductors; Cytokines; Inflammation of uterine appendages

Indexed keywords

CELL DNA; FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADNEXITIS; ADULT; APOPTOSIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; FIMBRIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; PATHOPHYSIOLOGY; STROMA CELL; UTERINE TUBE; UTERINE TUBE MUCOSA;

ADNEXAL DISEASES; ADULT; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; ENDOMETRIUM; FALLOPIAN TUBES; FEMALE; HUMANS; IN SITU NICK-END LABELING; INFLAMMATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

FALLOPIA;

EID: 0042813645     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023867830856     Document Type: Article

References (15)

1. A. V. Zhdanov, L. Yu. Sosulina, D. F. Kurbanova, et al., Byull. Eksp. Biol. Med., 134, No. 11, 555-559 (2002).
2. S. I. Rogovskaya, G. T. Sukhikh, A. V. Zhdanov, et al., Ibid., 131, No. 6, 576-582 (2001).
3. M. P. De Miguel, M. Royuela, F. R. Bethencourt, et al., Cytokine, 12, No. 5, 535-538 (2000).
4. N. Dunker and G. Aumuller, J. Anat., 201, Pt. 2, 173-183 (2002).
5. N. Dunker, K. Schmitt, N. Schuster, and K. Krieglstein, Gastroenterology, 122, No. 5, 1364-1375 (2002).
6. N. J. Gallagher, A. G. Eliopoulos, A. Agathangelo, et al., Mol. Pathol., 55, No. 2, 110-120 (2002).
7. P. Golstein, D. M. Ojcius, and J. D. Young, Immunol. Rev., 121, 29-65 (1991).
8. Y. W. Lee, H. Kuhn, B. Hennig, and M. Toborek, FEBS Lett., 485, Nos. 2-3, 122-126 (2000).
9. M. T. Lin, C. Y. Juan, K. J. Chang, et al., Carcinogenesis, 22, No. 12, 1947-1953 (2001).
10. S. K. Manna and B. B. Agarwal, J. Biol. Chem., 273, No. 50, 33,333-33,341 (1998).
11. M. J. Pinkoski, N. M. Droin, and D. R. Green, Ibid., 277, No. 44, 42,380-42,385 (2002).
12. I. Saito, Crit. Rev. Immunol., 20, No. 2, 153-165 (2000).
13. B. Selam, U. A. Kayisli, J. A. Garcia-Velasco, et al., J. Clin. Endocrinol. Metab., 87, No. 8, 3921-3927 (2002).
14. K. Smolnikar, S. Loffek, T. Schultz, et al., Breast Cancer Res. Treat., 63, No. 3, 249-259 (2000).
15. B. H. Sohn, H. B. Moon, T. Y. Kim, et al., Immunology 169, No. 8, 4288-4297 (2000).